Beauty Health (SKIN) to Release Quarterly Earnings on Tuesday

Beauty Health (NASDAQ:SKIN) will be announcing its earnings results after the market closes on Tuesday, November 12th. Analysts expect the company to announce earnings of ($0.12) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Beauty Health (NASDAQ:SKIN) last released its earnings results on Thursday, August 8th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.05). Beauty Health had a negative return on equity of 4.57% and a negative net margin of 22.86%. The company had revenue of $90.60 million for the quarter, compared to analyst estimates of $98.46 million. On average, analysts expect Beauty Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Beauty Health Price Performance

SKIN stock opened at $1.63 on Monday. The business’s 50-day moving average is $1.57 and its two-hundred day moving average is $1.91. The company has a debt-to-equity ratio of 7.96, a current ratio of 6.49 and a quick ratio of 5.47. The firm has a market capitalization of $202.15 million, a P/E ratio of -1.96 and a beta of 0.90. Beauty Health has a 1 year low of $0.91 and a 1 year high of $5.17.

Analyst Ratings Changes

Several brokerages recently weighed in on SKIN. Stifel Nicolaus reduced their target price on shares of Beauty Health from $4.00 to $2.00 and set a “hold” rating on the stock in a report on Friday, July 26th. Canaccord Genuity Group reduced their price objective on shares of Beauty Health from $2.00 to $1.25 and set a “hold” rating on the stock in a report on Monday, August 12th. Finally, Piper Sandler reiterated an “underweight” rating and set a $1.00 target price (down previously from $1.50) on shares of Beauty Health in a research note on Friday, August 9th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Beauty Health has a consensus rating of “Hold” and a consensus target price of $2.46.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.